Literature DB >> 12100037

Lupus-specific kidney deposits of HSP90 are associated with altered IgG idiotypic interactions of anti-HSP90 autoantibodies.

A Kenderov1, V Minkova, D Mihailova, N Giltiay, S Kyurkchiev, I Kehayov, M Kazatchkine, S Kaveri, A Pashov.   

Abstract

Previous studies have shown that autoantibodies to heat shock protein 90 (HSP90) are elevated in a significant proportion of patients with systemic lupus erythematosus (SLE) who are more likely to have renal disease and a low C3 level. Using samples from 24 patients, we searched for glomerular deposits of HSP90 in renal biopsy specimens from seven patients with lupus nephritis and 17 cases of glomerulonephritis from patients without SLE. Positive glomerular immunofluorescent staining for HSP90 was observed in six of seven cases of SLE and positive tubular staining in two of seven SLE patients. The staining for HSP90 was granular in nature and was located in subepithelial, subendothelial and mesangial areas. None of the non-SLE renal biopsies revealed positive staining for HSP90 deposition. Further we showed the presence of anti-HSP90 IgG autoantibodies in IgG from sera of patients with SLE as well as in normal human IgG (IVIg). In normal IgG this autoreactivity could be adsorbed almost completely on F(ab')2 fragments from the same IgG preparation, coupled to Sepharose and could be inhibited by the effluent obtained after subjecting normal IgG to HSP90 affinity column. These findings indicate that anti-HSP90 natural autoantibodies are blocked by idiotypic interactions within the IgG repertoire. Unlike natural autoantibodies, anti-HSP90 IgG from SLE patients' sera were only moderately adsorbed on F(ab')2 fragments of normal IgG. These results demonstrate that immunopathogenesis of lupus nephritis is associated with HSP90 (as an autoantigen) and that the pathology is associated with altered idiotypic regulation of the anti-HSP90 IgG autoantibodies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12100037      PMCID: PMC1906416          DOI: 10.1046/j.1365-2249.2002.01887.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  Etiopathogenesis of systemic lupus erythematosus.

Authors:  M Herrmann; R E Voll; J R Kalden
Journal:  Immunol Today       Date:  2000-09

2.  Lack of suppressive antibody activity in sera from patients with active-phase autoimmune diseases.

Authors:  J Melero; A Núñez-Roldán; D Tarragó; I Wichmann; B Sánchez
Journal:  Autoimmunity       Date:  1998       Impact factor: 2.815

3.  Anti-idiotypic antibodies prevent the serologic detection of antiribosomal P autoantibodies in healthy adults.

Authors:  Z J Pan; C J Anderson; H A Stafford
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

4.  Human polyreactive IgM monoclonal antibodies with blocking activity against self-reactive IgG.

Authors:  J Melero; D Tarragó; A Núñez-Roldán; B Sánchez
Journal:  Scand J Immunol       Date:  1997-04       Impact factor: 3.487

5.  Anti-DNA and antiphospholipid antibodies in IVIG preparations: in vivo study in naive mice.

Authors:  I Krause; M Blank; Y Shoenfeld
Journal:  J Clin Immunol       Date:  1998-01       Impact factor: 8.317

6.  Incidence and disease associations of a proteinase 3-antineutrophil cytoplasmic antibody idiotype (5/7 Id) whose antiidiotype inhibits proteinase 3-antineutrophil cytoplasmic antibody antigen binding activity.

Authors:  H P Strunz; E Csernok; W L Gross
Journal:  Arthritis Rheum       Date:  1997-01

7.  Autoantibodies to heat shock protein 90 in the human natural antibody repertoire.

Authors:  Anastas Pashov; Andrey Kenderov; Stanimir Kyurkchiev; Ivan Kehayov; Svetla Hristova; Sebastien Lacroix-Desmazes; Natalia Giltiay; Sooryanarayana Varamballi; Michael D Kazatchkine; Srini V Kaveri
Journal:  Int Immunol       Date:  2002-05       Impact factor: 4.823

8.  Abrogation of experimental systemic lupus erythematosus and primary antiphospholipid syndrome with intravenous gamma globulin.

Authors:  I Krause; M Blank; J Kopolovic; A Afek; I Goldberg; Y Tomer; Y Shoenfeld
Journal:  J Rheumatol       Date:  1995-06       Impact factor: 4.666

9.  Elevation of IL-6 in transgenic mice results in increased levels of the 90 kDa heat shock protein (hsp90) and the production of anti-hsp90 antibodies.

Authors:  A Stephanou; S Conroy; D A Isenberg; D Maione; V Poli; G Ciliberto; D S Latchman
Journal:  J Autoimmun       Date:  1998-06       Impact factor: 7.094

10.  Analysis of natural and disease-associated autoantibody repertoires: anti-endothelial cell IgG autoantibody activity in the serum of healthy individuals and patients with systemic lupus erythematosus.

Authors:  N Ronda; M Haury; A Nobrega; S V Kaveri; A Coutinho; M D Kazatchkine
Journal:  Int Immunol       Date:  1994-11       Impact factor: 4.823

View more
  13 in total

Review 1.  Heat shock proteins in the kidney.

Authors:  Rajasree Sreedharan; Scott K Van Why
Journal:  Pediatr Nephrol       Date:  2016-02-25       Impact factor: 3.714

2.  Identification of the pentapeptide constituting a dominant epitope common to all eukaryotic heat shock protein 90 molecular chaperones.

Authors:  Jun Kishimoto; Yutaka Fukuma; Akio Mizuno; Takayuki K Nemoto
Journal:  Cell Stress Chaperones       Date:  2005       Impact factor: 3.667

3.  The immunogenicity of humanized and fully human antibodies: residual immunogenicity resides in the CDR regions.

Authors:  Fiona A Harding; Marcia M Stickler; Jennifer Razo; Robert B DuBridge
Journal:  MAbs       Date:  2010-05-01       Impact factor: 5.857

4.  Heat shock protein 90 inhibition by 17-DMAG lessens disease in the MRL/lpr mouse model of systemic lupus erythematosus.

Authors:  Samuel K Shimp; Cristen B Chafin; Nicole L Regna; Sarah E Hammond; Molly A Read; David L Caudell; Marissanichole Rylander; Christopher M Reilly
Journal:  Cell Mol Immunol       Date:  2012-04-30       Impact factor: 11.530

5.  The expression of molecular chaperone HSP90 and IL-6 in patients with systemic lupus erythematosus.

Authors:  Shaoxian Hu; Qing Xu; Wenze Xiao; Melissa Huang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

Review 6.  Koebner's phenomenon in systemic lupus erythematosus.

Authors:  Barbara S Longhi; Maraisa Centeville; Roberto Marini; Simone Appenzeller
Journal:  Rheumatol Int       Date:  2011-03-25       Impact factor: 2.631

7.  The HSP90 Inhibitor Ganetespib Alleviates Disease Progression and Augments Intermittent Cyclophosphamide Therapy in the MRL/lpr Mouse Model of Systemic Lupus Erythematosus.

Authors:  Yuan Liu; Josephine Ye; Luisa Shin Ogawa; Takayo Inoue; Qin Huang; John Chu; Richard C Bates; Weiwen Ying; Andrew J Sonderfan; Patricia E Rao; Dan Zhou
Journal:  PLoS One       Date:  2015-05-14       Impact factor: 3.240

8.  A repertoire of 124 potential autoantigens for autoimmune kidney diseases identified by dermatan sulfate affinity enrichment of kidney tissue proteins.

Authors:  Wei Zhang; Jung-Hyun Rho; Michael W Roehrl; Michael H Roehrl; Julia Y Wang
Journal:  PLoS One       Date:  2019-06-25       Impact factor: 3.240

9.  Role of hsp90 in systemic lupus erythematosus and its clinical relevance.

Authors:  Hem D Shukla; Paula M Pitha
Journal:  Autoimmune Dis       Date:  2012-10-04

10.  Autoreactive IgE is prevalent in systemic lupus erythematosus and is associated with increased disease activity and nephritis.

Authors:  Barbara Dema; Christophe Pellefigues; Sarfaraz Hasni; Nathalie Gault; Chao Jiang; Tiffany K Ricks; Michael M Bonelli; Jörg Scheffel; Karim Sacré; Mathieu Jablonski; Delphine Gobert; Thomas Papo; Eric Daugas; Gabor Illei; Nicolas Charles; Juan Rivera
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.